| Issue Type | XXXX |
|---|---|
| Country | United Kingdom |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2033-12-19 |
| Par Value | 1000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 574.17 |
| Coupon | 5.25 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This GlaxoSmithKline Capital plc corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million GBP and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
GlaxoSmithKline Capital plc, founded in 2000 and based in the United Kingdom, serves as the financing arm of GlaxoSmithKline plc. The company’s primary purpose is to facilitate the group's funding needs through the issuance and management of debt instruments. Key services include the issuance of bonds to support the parent company's pharmaceutical and consumer healthcare operations.